Articles

Why 3 Biotechs Upgraded their EDC to Veeva Vault

Support for complex trials without reliance on custom functions, no downtime during amendments, and faster study build and close out. Emerging biotechs are updating their EDC to an innovative system that efficiently supports clinical trials. Here’s why organizations like yours made the switch to Veeva.

Learn how Cara Therapeutics cut build times as much as 60% with Veeva.

Interested in learning more about how Veeva can help?